Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 94Neoplasm Metastasis 9Prostatic Neoplasms, Castration-Resistant 5Breast Neoplasms 3Neoplasms 2Metastatic Castration Resistant Prostate Cancer 2Castration-resistant Prostate Cancer 2Urinary Bladder Neoplasms 1Stage II Prostate Adenocarcinoma 1Salivary Glands Tumors 1Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone 1Prostate Cancer Metastatic 1Prostate Adenocarcinoma 1Pharmacogenetic Study 1Oligometastatic Prostate Carcinoma 1Neoadjuvant Therapy 1Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1Metastatic Hormone Refractory Prostate Cancer 1Metastatic Castration-resistent Prostate Cancer 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castration-Resistant Prostate Cancer 1Dementia 1Cushing Syndrome 1Cognitive Dysfunction 1Castrate-resistant Prostate Cancer 1Carcinoma, Transitional Cell 1Cancer Pain 1Adrenocortical Carcinoma 1Adenocarcinoma 1

Interventions

Electroencephalography 2mazdutide 1enzalutamide 1amlodipine, atorvastatin drug combination 1Tomography, X-Ray Computed 1Tomography, Emission-Computed 1Tablets 1Standard of Care 1Referral and Consultation 1Prednisone 1Positron-Emission Tomography 1Methods 1Magnetic Resonance Imaging 1Lysine Acetyltransferase 5 1Hormones 1Gonadotropin-Releasing Hormone 1Exercise 1Ethanol 1Drug Delivery Systems 1Dignity Therapy 1Decision Support Techniques 1Atorvastatin 1Aging 1Activities of Daily Living 1Accidental Falls 1Abiraterone Acetate 17-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Dementia × Abiraterone Acetate × Clear all
NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Northwestern University

Phase 4 Active not recruiting
100 enrolled
Genitourinary

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡